The table below provides a historical record of Fisher & Paykel Healthcare's dividend payments and imputation credits.
1. Our shares were subdivided 5 for 1 on the 1st October 2004. The dividends and imputation credits above have been adjusted for the subdivision.
2. All dividends have been fully imputed other than the final dividend for the year ended 31 March 2008 paid on 27 June 2008 which was 50% imputed.
3. In addition to the above, the company has paid supplementary dividends to eligible non-New Zealand resident shareholders.
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment